Login / Signup

Safety of secukinumab treatment in COVID-19 affected psoriatic patients.

Cristina MughedduSilvia SannaLaura AtzoriFranco Rongioletti
Published in: Dermatologic therapy (2021)
Keyphrases
  • end stage renal disease
  • ankylosing spondylitis
  • coronavirus disease
  • ejection fraction
  • newly diagnosed
  • rheumatoid arthritis
  • peritoneal dialysis
  • prognostic factors
  • systemic lupus erythematosus
  • replacement therapy